Ruscogenin Attenuates Lipopolysaccharide-Induced Septic Vascular Endothelial Dysfunction by Modulating the miR-146a-5p/NRP2/SSH1 Axis
Danhong Pan,1 Jinqiang Zhu,2 Liexiang Cao,2 Beilei Zhu,3 Lili Lin1 1Emergency Care Unit, The First People’s Hospital of Wenling, Wenling, Zhejiang, 317500, People’s Republic of China; 2Emergency Department, The First People’s Hospital of Wenling, Wenling, Zhejiang, 317500, People’s Republic of China...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2022-04-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/ruscogenin-attenuates-lipopolysaccharide-induced-septic-vascular-endot-peer-reviewed-fulltext-article-DDDT |
| _version_ | 1830133777038311424 |
|---|---|
| author | Pan D Zhu J Cao L Zhu B Lin L |
| author_facet | Pan D Zhu J Cao L Zhu B Lin L |
| author_sort | Pan D |
| collection | DOAJ |
| description | Danhong Pan,1 Jinqiang Zhu,2 Liexiang Cao,2 Beilei Zhu,3 Lili Lin1 1Emergency Care Unit, The First People’s Hospital of Wenling, Wenling, Zhejiang, 317500, People’s Republic of China; 2Emergency Department, The First People’s Hospital of Wenling, Wenling, Zhejiang, 317500, People’s Republic of China; 3Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, People’s Republic of ChinaCorrespondence: Lili Lin, Emergency Care Unit, The First People’s Hospital of Wenling, No. 333, Chuan’an South Road, Chengxi Street, Wenling, Zhejiang, 317500, People’s Republic of China, Tel +86– 13616760809, Email lllin_24126_zh@hotmail.comIntroduction: Endothelial dysfunction (ED) is associated with the progression of sepsis. Ruscogenin (RUS) has shown considerable efficacy in treating ED and sepsis. In the current study, the effects of RUS on sepsis-induced ED were assessed, and the mechanism was explored by focusing on the interactions of RUS with miRs.Methods: Sepsis was induced in mice and in human umbilical vein endothelial cells (HUVECs) using LPS method. Expression profile of miRs responding to sepsis was determined. Symptoms associated with sepsis and ED were examined after treatment with RUS. Changes in mouse survival, arterial structure, systemic inflammation, cell viability, apoptosis, and the miR-146a-5p/NRP2/SSH1 axis were analyzed.Results: Based on the microarray results, miR-146a-5p was selected as the therapeutic target. RUS improved survival rates and arterial structure, suppressed proinflammatory cytokines, down-regulated miR-146a-5p, and up-regulated NPR2 and SSH1 in septic mice. In HUVECs, RUS increased cell viability, suppressed apoptosis, inhibited inflammation, downregulated miR-146a-5p, and increased NRP2 and SSH1 levels. The re-induction of miR-146a-5p-5p impaired the protective effects of RUS on HUVECs.Discussion: Effects of RUS on sepsis-induced impairments in endothelium relied on the suppression of miR-146a-5p.Keywords: endothelial dysfunction, ruscogenin, miR-146a-5p, NRP2, sepsis |
| first_indexed | 2024-12-17T06:59:24Z |
| format | Article |
| id | doaj.art-e894fd823a8b4e08bfb64fdd390cffe1 |
| institution | Directory Open Access Journal |
| issn | 1177-8881 |
| language | English |
| last_indexed | 2024-12-17T06:59:24Z |
| publishDate | 2022-04-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Drug Design, Development and Therapy |
| spelling | doaj.art-e894fd823a8b4e08bfb64fdd390cffe12022-12-21T21:59:18ZengDove Medical PressDrug Design, Development and Therapy1177-88812022-04-01Volume 161099110674433Ruscogenin Attenuates Lipopolysaccharide-Induced Septic Vascular Endothelial Dysfunction by Modulating the miR-146a-5p/NRP2/SSH1 AxisPan DZhu JCao LZhu BLin LDanhong Pan,1 Jinqiang Zhu,2 Liexiang Cao,2 Beilei Zhu,3 Lili Lin1 1Emergency Care Unit, The First People’s Hospital of Wenling, Wenling, Zhejiang, 317500, People’s Republic of China; 2Emergency Department, The First People’s Hospital of Wenling, Wenling, Zhejiang, 317500, People’s Republic of China; 3Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, People’s Republic of ChinaCorrespondence: Lili Lin, Emergency Care Unit, The First People’s Hospital of Wenling, No. 333, Chuan’an South Road, Chengxi Street, Wenling, Zhejiang, 317500, People’s Republic of China, Tel +86– 13616760809, Email lllin_24126_zh@hotmail.comIntroduction: Endothelial dysfunction (ED) is associated with the progression of sepsis. Ruscogenin (RUS) has shown considerable efficacy in treating ED and sepsis. In the current study, the effects of RUS on sepsis-induced ED were assessed, and the mechanism was explored by focusing on the interactions of RUS with miRs.Methods: Sepsis was induced in mice and in human umbilical vein endothelial cells (HUVECs) using LPS method. Expression profile of miRs responding to sepsis was determined. Symptoms associated with sepsis and ED were examined after treatment with RUS. Changes in mouse survival, arterial structure, systemic inflammation, cell viability, apoptosis, and the miR-146a-5p/NRP2/SSH1 axis were analyzed.Results: Based on the microarray results, miR-146a-5p was selected as the therapeutic target. RUS improved survival rates and arterial structure, suppressed proinflammatory cytokines, down-regulated miR-146a-5p, and up-regulated NPR2 and SSH1 in septic mice. In HUVECs, RUS increased cell viability, suppressed apoptosis, inhibited inflammation, downregulated miR-146a-5p, and increased NRP2 and SSH1 levels. The re-induction of miR-146a-5p-5p impaired the protective effects of RUS on HUVECs.Discussion: Effects of RUS on sepsis-induced impairments in endothelium relied on the suppression of miR-146a-5p.Keywords: endothelial dysfunction, ruscogenin, miR-146a-5p, NRP2, sepsishttps://www.dovepress.com/ruscogenin-attenuates-lipopolysaccharide-induced-septic-vascular-endot-peer-reviewed-fulltext-article-DDDTendothelial dysfunctionruscogeninmir-146a-5pnrp2sepsis |
| spellingShingle | Pan D Zhu J Cao L Zhu B Lin L Ruscogenin Attenuates Lipopolysaccharide-Induced Septic Vascular Endothelial Dysfunction by Modulating the miR-146a-5p/NRP2/SSH1 Axis Drug Design, Development and Therapy endothelial dysfunction ruscogenin mir-146a-5p nrp2 sepsis |
| title | Ruscogenin Attenuates Lipopolysaccharide-Induced Septic Vascular Endothelial Dysfunction by Modulating the miR-146a-5p/NRP2/SSH1 Axis |
| title_full | Ruscogenin Attenuates Lipopolysaccharide-Induced Septic Vascular Endothelial Dysfunction by Modulating the miR-146a-5p/NRP2/SSH1 Axis |
| title_fullStr | Ruscogenin Attenuates Lipopolysaccharide-Induced Septic Vascular Endothelial Dysfunction by Modulating the miR-146a-5p/NRP2/SSH1 Axis |
| title_full_unstemmed | Ruscogenin Attenuates Lipopolysaccharide-Induced Septic Vascular Endothelial Dysfunction by Modulating the miR-146a-5p/NRP2/SSH1 Axis |
| title_short | Ruscogenin Attenuates Lipopolysaccharide-Induced Septic Vascular Endothelial Dysfunction by Modulating the miR-146a-5p/NRP2/SSH1 Axis |
| title_sort | ruscogenin attenuates lipopolysaccharide induced septic vascular endothelial dysfunction by modulating the mir 146a 5p nrp2 ssh1 axis |
| topic | endothelial dysfunction ruscogenin mir-146a-5p nrp2 sepsis |
| url | https://www.dovepress.com/ruscogenin-attenuates-lipopolysaccharide-induced-septic-vascular-endot-peer-reviewed-fulltext-article-DDDT |
| work_keys_str_mv | AT pand ruscogeninattenuateslipopolysaccharideinducedsepticvascularendothelialdysfunctionbymodulatingthemir146a5pnrp2ssh1axis AT zhuj ruscogeninattenuateslipopolysaccharideinducedsepticvascularendothelialdysfunctionbymodulatingthemir146a5pnrp2ssh1axis AT caol ruscogeninattenuateslipopolysaccharideinducedsepticvascularendothelialdysfunctionbymodulatingthemir146a5pnrp2ssh1axis AT zhub ruscogeninattenuateslipopolysaccharideinducedsepticvascularendothelialdysfunctionbymodulatingthemir146a5pnrp2ssh1axis AT linl ruscogeninattenuateslipopolysaccharideinducedsepticvascularendothelialdysfunctionbymodulatingthemir146a5pnrp2ssh1axis |